Skip to main content

AlphaLISA versus ELISA-based detection of interleukin 18 in healthy subjects and patients with end-stage renal disease.

Peters CD, Jespersen B, Nørregaard R

Publication: Scand J Clin Lab Invest (2012) • Vol 72 • Page 583-92PMID: 22935048View on PubMed

Purpose

The purpose of this paper was to determine the effects of whole blood storage temperature and duration, freeze-thaw cycling, hemolysis, plasma additives and assay type on interleukin (IL)-18 concentrations in plasma.

Conclusion

While storing blood specimens for up to 24 h at 5 degrees C had no effect on IL-18 concentrations in plasma, significant declines in plasma IL-18 were noted after room temperature storage of blood. Subjecting plasma to up to 6 freeze-thaw cycles, low levels of hemolysis or adding phosphate buffer or mouse IgG had no effects on IL-18 levels, but severe hemolysis or adding mouse serum increased mean IL-18 levels. After storing plasma for 0-424 days at -80 degrees C, the coefficient of variance (CV) of IL-18 in plasma was 8.8% when assayed by ELISA. However, storing plasma for 0-312 days at -80 degrees C resulted in a CV of 59.2% when plasma IL-18 was assayed by AlphaLISA.

Studies (1)

Purpose

The purpose of this study was to determine the effects of whole blood storage temperature and duration, freeze-thaw cycling, hemolysis, plasma additives and assay type on IL-18 concentrations in plasma from healthy volunteers and patients with end-stage renal disease (ESRD). All plasma specimens were stored at -80 degrees C prior to analysis.

Summary of Findings

While storing blood specimens for up to 24 h at 5 degrees C had no effect on IL-18 concentrations in plasma, significant declines in plasma IL-18 were noted after room temperature storage of blood (24 h versus 0 or 1 h, and 6 versus 1 h, all p<0.05). Subjecting plasma to up to 6 freeze-thaw cycles, low levels of hemolysis or adding phosphate buffer or mouse IgG had no effects on IL-18 levels, but severe hemolysis or adding mouse serum increased mean IL-18 levels (p=0.0040 and p=0.036, respectively). After storing plasma for 0-424 days at -80 degrees C, the CV of IL-18 in plasma was 8.8% when assayed by ELISA. However, storing plasma for 0-312 days at -80 degrees C resulted in a CV of 59.2% when plasma IL-18 was assayed by AlphaLISA. The intraassay, interassay, and batch to batch CVs for IL-18, as well as the detection limits, were all higher by AlphaLISA than by ELISA, and IL-18 concentrations were higher when measured by AlphaLISA than by ELISA. Using both methods, IL-18 levels were significantly higher in patients with ESRD than in healthy volunteers (p<0.0005).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Other diagnoses
    Normal
  • Platforms

    ProteinELISA
    ProteinChemiluminescence immunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    End-stage renal disease
    Healthy
    Biospecimen Aliquots and ComponentsBiospecimen components
    Mouse serum added
    No additive
    Phosphate buffer added
    Polyclonal mouse IgG added
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    Biospecimen Aliquots and ComponentsHemolysis
    Freeze/thaw-induced
    Not induced
    Pipette tip-induced
    StorageFreeze/thaw cycling
    1 cycle
    2 cycles
    3 cycles
    4 cycles
    5 cycles
    6 cycles
    StorageStorage duration
    0 h
    0-312 h
    0-424 h
    1 h
    24 h
    6 h
    StorageStorage temperature
    -80 degrees C
    5 degrees C
    Room temperature
    ELISA SpecificTechnology platform
    AlphaLISA